Addex Therapeutics Ltd (ADXN)
8.800
+0.01
(+0.11%)
USD |
NASDAQ |
May 20, 16:00
8.90
+0.10
(+1.14%)
After-Hours: 20:00
Addex Therapeutics 1 Year Total Returns (Daily): -44.37% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 17, 2024 | -44.37% |
May 16, 2024 | -41.80% |
May 15, 2024 | -46.59% |
May 14, 2024 | -46.33% |
May 13, 2024 | -47.01% |
May 10, 2024 | -50.46% |
May 09, 2024 | -40.06% |
May 08, 2024 | -38.36% |
May 07, 2024 | -37.09% |
May 06, 2024 | -37.09% |
May 03, 2024 | -38.14% |
May 02, 2024 | -41.58% |
May 01, 2024 | -46.62% |
April 30, 2024 | -46.10% |
April 29, 2024 | -46.88% |
April 26, 2024 | 7.36% |
April 25, 2024 | 2.73% |
April 24, 2024 | 7.52% |
April 23, 2024 | 24.95% |
April 22, 2024 | 28.55% |
April 19, 2024 | 35.66% |
April 18, 2024 | 57.97% |
April 17, 2024 | 47.73% |
April 16, 2024 | 45.74% |
April 15, 2024 | 59.61% |
Date | Value |
---|---|
April 12, 2024 | 59.81% |
April 11, 2024 | 65.97% |
April 10, 2024 | 78.62% |
April 09, 2024 | 91.10% |
April 08, 2024 | 49.66% |
April 05, 2024 | 18.13% |
April 04, 2024 | -11.29% |
April 03, 2024 | -22.49% |
April 02, 2024 | -30.04% |
April 01, 2024 | -31.30% |
March 28, 2024 | -43.36% |
March 27, 2024 | -42.82% |
March 26, 2024 | -48.06% |
March 25, 2024 | -49.16% |
March 22, 2024 | -51.17% |
March 21, 2024 | -47.84% |
March 20, 2024 | -48.74% |
March 19, 2024 | -45.30% |
March 18, 2024 | -45.55% |
March 15, 2024 | -46.77% |
March 14, 2024 | -56.88% |
March 13, 2024 | -47.88% |
March 12, 2024 | -53.57% |
March 11, 2024 | -53.33% |
March 08, 2024 | -57.09% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-91.96%
Minimum
Sep 22 2022
91.10%
Maximum
Apr 09 2024
-47.22%
Average
-54.57%
Median
Mar 02 2022
1 Year Total Returns (Daily) Benchmarks
AC Immune SA | 52.15% |
CRISPR Therapeutics AG | -12.72% |
NLS Pharmaceutics Ltd | -85.61% |
Molecular Partners AG | -41.85% |
MoonLake Immunotherapeutics | 41.16% |